Publication Author: Basu_Anirban

• Payer Preferences and Willingness to Pay for Genomic Precision Medicine: A Discrete Choice Experiment.

  Dhanda DS, Veenstra DL, Regier DA, Basu A, Carlson JJ. Payer Preferences and Willingness to Pay for Genomic Precision Medicine: A Discrete Choice Experiment. J Manag Care Spec Pharm. 2020 Apr;26(4):529-537. doi: 10.18553/jmcp.2020.26.4.529.

  rakerr2

  April 1, 2020

• Washington’s privatization of liquor: effects on household alcohol purchases from Initiative 1183.

  Barnett SBL, Coe NB, Harris JR, Basu A. Washington’s privatization of liquor: effects on household alcohol purchases from Initiative 1183. Addiction. 2020 Apr;115(4):681-689. doi: 10.1111/add.14875. Epub 2020 Feb 5.

  rakerr2

  April 1, 2020

• Health Economics Tools and Precision Medicine: Opportunities and Challenges.

  Veenstra DL, Mandelblatt J, Neumann P, Basu A, Peterson JF, Ramsey SD. Health Economics Tools and Precision Medicine: Opportunities and Challenges. Forum Health Econ Policy. 2020 Mar 5. pii: /j/fhep.ahead-of-print/fhep-2019-0013/fhep-2019-0013.xml. doi: 1

  rakerr2

  March 5, 2020

• A welfare-theoretic model consistent with the practice of cost-effectiveness analysis and its implications.

  Basu A. A welfare-theoretic model consistent with the practice of cost-effectiveness analysis and its implications. J Health Econ. 2020 Mar;70:102287. doi: 10.1016/j.jhealeco.2020.102287. Epub 2020 Jan 11.

  rakerr2

  March 1, 2020

• Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.

  Rothery C, Strong M, Koffijberg HE, Basu A, Ghabri S, Knies S, Murray JF, Sanders Schmidler GD, Steuten L, Fenwick E. Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. Value He

  rakerr2

  March 1, 2020

• Assessing Health Care Burden in Glaucoma Patients with and Without Physical or Mental Comorbidities.

  Serbin M, Devine B, Campbell J, Basu A. Assessing Health Care Burden in Glaucoma Patients with and Without Physical or Mental Comorbidities. J Manag Care Spec Pharm. 2020 Mar;26(3):325-331. doi: 10.18553/jmcp.2020.26.3.325.

  rakerr2

  March 1, 2020

• Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.

  Fenwick E, Steuten L, Knies S, Ghabri S, Basu A, Murray JF, Koffijberg HE, Strong M, Sanders Schmidler GD, Rothery C. Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good P

  rakerr2

  February 1, 2020

• Health Years in Total: A New Health Objective Function for Cost-Effectiveness Analysis.

  Basu A, Carlson J, Veenstra D. Health Years in Total: A New Health Objective Function for Cost-Effectiveness Analysis. Value Health. 2020 Jan;23(1):96-103. doi: 10.1016/j.jval.2019.10.014. Epub 2019 Dec 24.

  rakerr2

  January 1, 2020

• Dementia Is Associated With Earlier Mortality for Men and Women in the United States.

  White L, Fishman P, Basu A, Crane PK, Larson EB, Coe NB. Dementia Is Associated With Earlier Mortality for Men and Women in the United States. Gerontol Geriatr Med. 2020 Aug 19;6:2333721420945922. doi: 10.1177/2333721420945922. eCollection 2020 Jan-Dec.

  rakerr2

  January 1, 2020

• Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States.

  Carlson JJ, Walton SM, Basu A, Chapman RH, Campbell JD, McQueen RB, Pearson SD, Touchette DR, Veenstra D, Whittington MD, Ollendorf DA. Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the Un

  rakerr2

  November 1, 2019